Ligand Pharmaceuticals Incorporated (LGND)

USD 114.41

(-5.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 833.06 Million 762.66 Million 1.3 Billion 1.36 Billion 1.46 Billion 1.26 Billion
Total Current Assets 237.42 Million 263.6 Million 464.75 Million 500.55 Million 1.12 Billion 870.54 Million
Cash And Short Term Investments 170.3 Million 211.87 Million 341.1 Million 411.18 Million 1.06 Billion 764.57 Million
Cash and Cash Equivalents 22.95 Million 45 Thousand 19.52 Million 47.61 Million 1.01 Billion 718.38 Million
Short Term Investments 147.35 Million 166.86 Thousand 321.58 Million 363.56 Million 58.33 Million 46.19 Million
Net Receivables 39.31 Million 35.03 Million 91.64 Million 59.06 Million 41.74 Million 55.85 Million
Inventory 23.96 Million 13.29 Million 27.32 Million 26.48 Million 7.29 Million 7.12 Million
Other Current Assets 3.83 Million 3.39 Million 4.67 Million 3.82 Million 4.73 Million 20.41 Million
Total Non-Current Assets 595.63 Million 499.06 Million 836.63 Million 861.72 Million 345.66 Million 390.26 Million
Net PPE 9.45 Million 15 Million 32.74 Million 22.73 Million 10.35 Million 5.37 Million
Good Will And Intangible Assets 470.26 Million 458.31 Million 745.1 Million 795.97 Million 325.76 Million 337.89 Million
Good Will 103.37 Million 448.12 Million 734.99 Million 784.99 Million 305.67 Million 306.43 Million
Intangible Assets 366.89 Million 10.18 Million 10.11 Million 10.97 Million 20.09 Million 31.46 Million
Long-Term Investments 48.32 Million 3 Million - - -25.6 Million 601.21 Million
Tax Assets 46.06 Million 8.53 Million 35.52 Million 24.32 Million 25.6 Million 46.52 Million
Other Non Current Assets 21.53 Million 14.21 Million 23.25 Million 18.7 Million 9.54 Million -600.74 Million
Other Assets - - - - - -
Total Liabilities 130.7 Million 165.18 Million 479.75 Million 652.76 Million 702.07 Million 699.88 Million
Total Current Liabilities 16.78 Million 98.81 Million 41.66 Million 100.11 Million 17 Million 82.24 Million
Account Payables 14.89 Million 5307.00 8.4 Million 3.78 Million 2.42 Million 23.38 Million
Tax Payables - - - - - -
Short Term Debt 410 Thousand 77.41 Million 46 Thousand 6.59 Million 1.24 Million 26.43 Million
Deferred Revenue 1.22 Million 355 Thousand 10.99 Million 29.43 Million 2.13 Million 3.28 Million
Other Current Liabilities 256 Thousand 21.03 Million 22.22 Million 60.29 Million 11.2 Million 29.14 Million
Total Non Current Liabilities 113.92 Million 66.37 Million 438.08 Million 552.64 Million 685.07 Million 617.64 Million
Long-Term Debt 5.75 Million 10.33 Million 336.21 Million 447.93 Million 648.92 Million 609.86 Million
Deferred Revenue Non Current 15.14 Million 30.61 Million - - - -51.96 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 15.55 Million -5.19 Million 39.45 Million 40.11 Million 28.81 Million 7.77 Million
Other Liabilities - - - - - -
Total Equity 700.91 Million 597.48 Million 821.62 Million 709.52 Million 767.23 Million 560.91 Million
Stock Holders Equity 700.91 Million 597.48 Million 821.62 Million 709.52 Million 767.23 Million 560.91 Million
Common Stock 18 Thousand 17.00 17 Thousand 16 Thousand 17 Thousand 21 Thousand
Retained Earnings 503.01 Million 450.86 Thousand 449.09 Million 391.95 Million 400.1 Million -229.19 Million
Accumulated other comprehensive income -817 Thousand -984.00 -917 Thousand -801 Thousand -216 Thousand -1.02 Million
Common Stock Equity 700.91 Million 597.48 Million 821.62 Million 709.52 Million 767.23 Million 560.91 Million
Capital Lease Obligation 5.75 Million 11.05 Million 15.54 Million 12.23 Million 9.97 Million -
Total Investments 195.67 Million 166.86 Thousand 321.58 Million 363.56 Million 58.33 Million 647.4 Million
Total Debt 6.16 Million 87.74 Million 336.25 Million 454.52 Million 648.92 Million 636.29 Million
Net Debt -16.78 Million 87.7 Million 316.73 Million 406.91 Million -362.6 Million -82.08 Million

Balance Sheet Charts